Viewing Study NCT02044120

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:27 AM

Ignite Modification Date: 2026-03-14 @ 9:23 PM

Study NCT ID: NCT02044120

Status: COMPLETED

Last Update Posted: 2021-01-12

First Post: 2014-01-21

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma

Sponsor: Sarcoma Alliance for Research through Collaboration

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Annotation Module